Fibroheal Woundcare
Bengaluru, India· Est.
Silk‑protein‑based wound‑care solutions for faster, affordable healing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Silk‑protein‑based wound‑care solutions for faster, affordable healing.
DermatologyRegenerative MedicineWound Care
Technology Platform
Proprietary extraction and processing of silk proteins into non‑textile biomaterials for hemostasis, antimicrobial activity, and tissue regeneration in wound‑care applications.
Opportunities
Expansion into emerging markets (Middle East, Africa) and development of next‑generation silk‑protein dressings with embedded growth factors or nanomedicines.
Risk Factors
Regulatory approval hurdles, competition from established global wound‑care brands, and scaling manufacturing while maintaining quality standards.
Competitive Landscape
Competes with synthetic and cellulose‑based dressings from 3M, Smith & Nephew, and emerging silk‑protein firms like Kerecis; differentiation lies in proprietary silk‑protein biomaterial and domestic manufacturing cost advantage.